Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                FDA’s Labeling Resources for Human Prescription Drugs

FDA’s Labeling Resources for Human Prescription Drugs

                        Prescribing Information Resources
          Patient Labeling Resources
          Carton and Container Labeling Resources
          Selection of Appropriate SPL Codes for Human Prescription Drug Labeling
          Generic Drugs - Specific Labeling Resources
          Biological Products - Specific Labeling Resources
          Frequently Asked Questions about Labeling for Prescription Medicines
          Prescription Drug Labeling Contact Information Home
          Drugs
          Guidance, Compliance, & Regulatory Information
          Laws, Acts, and Rules
          FDA’s Labeling Resources for Human Prescription Drugs
          Generic Drugs - Specific Labeling ResourcesFDA’s Labeling Resources for Human Prescription Drugs Generic Drugs - Specific Labeling Resources
  
  					For Industry
	
    Subscribe to Email Updates
    Share
    Post
    Linkedin

    Email
    PrintWho Is the Audience for This Website?

FDA’s generic drug-specific labeling resources are primarily directed to industry staff who develop generic drug labeling. For more information about:

Other prescription drug labeling resources for industry such as those for the Prescribing Information, FDA-approved patient labeling, carton and container labeling, biological product labeling, labeling databases, and product databases visit FDA’s Labeling Resources for Human Prescription Drugs.
	Drug labeling resources for healthcare professionals, patients, and caregivers, visit Frequently Asked Questions about Labeling for Prescription MedicinesGeneric Drug Labeling

Generic drug labeling [labeling under an abbreviated new drug application (ANDA)] must be the “same as” the last approved reference listed drug (RLD) labeling except for permissible differences (e.g., manufacturer/packer/distributor information, package size, inactive ingredients, omission of information protected by patent or exclusivity, differences due to an approved suitability petition).

Updating Generic Drug Labeling

ANDA holders are expected to promptly update their generic drug labeling (ANDA labeling) after FDA has approved changes to the associated RLD labeling.  Prompt revision, submission to the FDA, and implementation of revised ANDA labeling are important to ensure that the generic drug continues to be as safe and effective as the corresponding RLD.

ANDA holders should routinely review the last approved RLD labeling on Drugs@FDA to ensure that their ANDA labeling meets the “same as” requirements. For email updates about RLD labeling supplement approvals, subscribe to CDER Drug Safety Labeling Changes. ANDA holders can also obtain the last approved RLD labeling from FDA’s Division of Freedom of Information via online request, fax (301-827-9267), or mail (FDA Division of Freedom of Information Office of the Executive Secretariat, OC 5630 Fishers Lane, Room 1035 Rockville, MD 20857).

Labeling for certain ANDAs associated with a withdrawn reference listed drug (RLD) may be updated under the MODERN Labeling Act of 2020 when updating the ANDA labeling would benefit the public health and:

There is new scientific evidence available pertaining to the existing conditions of use that is not reflected in the labeling
	The approved labeling does not reflect current legal and regulatory requirements for content or format; or
	There is a relevant accepted use in clinical practice that is not reflected in the approved labelingGeneric Drug-Specific Labeling Legislation/Regulations

MODERN Labeling Act of 2020
	Section 505(j)(2)(A)(v) of the FD&C Act and 21 CFR 314.94(a)(8)(iv).Generic Drug-Specific Labeling Guidances and MAPP

Acceptability of Draft Labeling to Support ANDA Approval (final guidance)
	Determining Whether to Submit an ANDA or a 505(b)(2) Application (final guidance)
	Generic Drug Labeling Revisions Under Section 505(j)(10) of the Federal Food, Drug, and Cosmetic Act MAPP (MAPP 5230.3 Revision 1)
	Good ANDA Submission Practices (draft guidance)
	Orange Book Questions and Answers (final guidance)
	Referencing Approved Drug Products in ANDA Submissions (final guidance)
	Revising ANDA Labeling Following Revision of the RLD Labeling (draft guidance)
	Systemic Antibacterial and Antifungal Drugs: Susceptibility Test Interpretive Criteria Labeling for NDAs and ANDAs (final guidance)
	Updating ANDA Labeling After the Marketing Application for the Reference Listed Drug Has Been Withdrawn (draft guidance)Other Generic Drug-Specific Labeling Resources

FDA’s List of Established Drug Names Recommended to Use Tall Man Lettering
	Orange Book is a searchable online database containing FDA-approved drugs with therapeutic equivalence evaluations on the basis of safety and effectiveness under the Federal Food, Drug, and Cosmetic Act and related patent and exclusivity information.
	United States Pharmacopeia General Chapter <7> (Labeling) provides definitions and labeling standards for official USP articles including strength expression for injectable products, pharmacy bulk packages, imaging bulk packages, labeling for ferrules and cap overseals, aluminum use in parenteral nutrition, and expiration and beyond the use date.Contact Information

For specific application or supplement questions or for general questions about prescription drug labeling, please visit Prescription Drug Labeling Contact Information.

                                                                                  Content current as of:
      08/08/2022
              
              
Regulated Product(s)
		 DrugsFDA’s Labeling Resources for Human Prescription Drugs

          
                        Prescribing Information Resources
          Patient Labeling Resources
          Carton and Container Labeling Resources
          Selection of Appropriate SPL Codes for Human Prescription Drug Labeling
          Generic Drugs - Specific Labeling Resources
          Biological Products - Specific Labeling Resources
          Frequently Asked Questions about Labeling for Prescription Medicines
          Prescription Drug Labeling Contact Information
 SUBSCRIBE
                    Get email updates about RLD labeling supplement approvals
    Enter your email address to subscribe:
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop